🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Alzheimer's disease (AD) is an age-related degenerative disorder of the bra...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2009-05
Trial ID
NCT00905372
The purpose of this study is to investigate the safety, tolerability, pharm...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2008-09
Trial ID
NCT00749216
Treatments Being Tested
The purpose of this study is to test whether an investigational drug called...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-02-28
Trial ID
NCT02008357
Treatments Being Tested
To test the idea that solanezumab will slow the cognitive decline of Alzhei...
Status
Terminated
Location
Xenoscience
Start Date
2013-07
Trial ID
NCT01900665
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, biomarker ...
Status
Completed
Location
University of Alabama in Birmingham
Start Date
2012-12
Trial ID
NCT04623242
Treatments Being Tested
The purpose of this trial is to compare the average change in the amount of...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-08
Trial ID
NCT01148498
Treatments Being Tested
To study the safety of LY2062430 in patients with mild-to-moderate Alzheime...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2006-05
Trial ID
NCT00329082
The main purpose of this study is to investigate the safety and efficacy of...
Status
Terminated
Location
Xenoscience
Start Date
2016-06
Trial ID
NCT02760602
Treatments Being Tested
This study is an open-label extension study in Alzheimer's patients who hav...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-12
Trial ID
NCT01127633
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, biomarker,...
Status
Active Not Recruiting
Location
University of Alabama in Birmingham
Start Date
2012-12
Trial ID
NCT01760005